11.12.2012 17:40
Bewerten
 (0)

In France, GE Healthcare Announces the First Global Installation of Its Discovery IGS 730 System for Hybrid Operating Rooms

GE Healthcare announces the first global installation in France of the Discovery IGS 730 system for hybrid Operating Rooms and imaging departments. It will allow performing complex minimally-invasive endovascular and percutaneous procedures on inoperable patients suffering from cardiovascular pathologies such as ruptured aorta aneurysms, fainting spells or cerebrovascular accidents. "The Discovery IGS 730 is a true innovation allowing us to conduct complex minimally invasive hybrid procedures in a secure setting. With this technology we are treating "high risk” patients unfit for open surgery. In a year, this technology will allow us to perform 500 complex aortic repairs in such patients. The majority of patients will have a reduced hospital stay and a quick return to normal activity. In addition, in terms of mobility/patient access and the ergonomics of the operating room, this is a huge step forward”, said Prof. Haulon, Head of Vascular Surgery Department, University Hospital of Lille, France.

World's first installation and clinical use of GE Healthcare’s Discovery IGS 730 at the Lille Univer ...

World's first installation and clinical use of GE Healthcare’s Discovery IGS 730 at the Lille University Hospital in France.

A major innovation developed and produced in France: Discovery IGS 730

The hybrid operating room allows both open surgery and catheter-based imaging therapies to take place in the same operating room. The hybrid OR enables multiple physicians (surgeons, Interventionalist, nurses, anaesthesiologists, and technicians) to perform a new spectrum of minimally invasive therapies with the goal of ultimately enabling better patient care. These complex minimally-invasive endovascular and percutaneous procedures will allow discharging patients much faster (5 days in comparison to an average of 10 days) and reduce patient rehabilitation.

"In designing the Discovery IGS 730, it was always our goal to provide the latest in interventional efficiency – with high precision imaging capability and exceptional in-room mobility. This solution aims to accommodate a wide range of minimally invasive and surgical procedures. Due to the technological innovation and the advanced application portfolio available, we hope it will allow our customers to explore and discover new ways within both the Interventional and the Operating Room.” says Chantal Le Chat, General Manager, Premium Angiography, GE Healthcare, Detection & Guidance Solutions.

The Discovery IGS 730 is a laser-guided, mobile gantry, a first-of-its kind in interventional imaging. The system is neither floor nor ceiling mounted and enables full patient access, creating an interventional environment without boundaries. It has the mobility of a C-arm with the power and image quality of a fixed system, allowing multiple parking possibilities, while helping maintain sterility for a flexible and secure OR environment. It is intended for oncology (hepatic and bone tumors), neurology (aneurysms and brain tumors) as well as cardiovascular patients (stent appositions). Discovery IGS 730 is the only x-ray angiographic medical imaging system with such mobility in the world.

Discovery IGS 730, the outcome of a 32 million Euros investment in France

In total, 12 international patents have been registered for this ground-breaking technological innovation. Discovery IGS 730 has been developed within the IRIMI project, a public-private partnership that involved several French laboratories and partially funded by the French government (IRIMI project).

"With the installation of the Discovery IGS 730 in France, our R&D factory of Buc (Parisian Region) has become the birthplace of a ground-breaking innovation in worldwide surgery. With this, our 420 France-based researchers have proven to be able to find technological innovations that allow new treatments, reduce risks for the patients and provide solutions for health professionals” declared Robert Sigal, CEO, GE Healthcare France.

About GE Healthcare

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems. Our "healthymagination” vision for the future invites the world to join us on our journey as we continuously develop innovations focused on increasing access and improving quality and affordability around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com. For our latest news, please visit http://newsroom.gehealthcare.com.

Artikel empfehlen?

Nachrichten zu General Electric (GE) Co.

  • Relevant
  • Alle
  • vom Unternehmen
  • Peer Group
  • ?
Um Ihnen die Übersicht über die große Anzahl an Nachrichten, die jeden Tag für ein Unternehmen erscheinen, etwas zu erleichtern, haben wir den Nachrichtenfeed in folgende Kategorien aufgeteilt:

Relevant: Nachrichten von ausgesuchten Quellen, die sich im Speziellen mit diesem Unternehmen befassen
Alle: Alle Nachrichten, die dieses Unternehmen betreffen. Z.B. auch Marktberichte die außerdem auch andere Unternehmen betreffen
vom Unternehmen: Nachrichten und Adhoc-Meldungen, die vom Unternehmen selbst veröffentlicht werden
Peer Group: Nachrichten von Unternehmen, die zur Peer Group gehören

Analysen zu General Electric (GE) Co.

  • Alle
  • Buy
  • Hold
  • Sell
  • ?
17.12.2014General Electric (GE) OutperformRBC Capital Markets
25.11.2014General Electric (GE) OutperformRBC Capital Markets
17.09.2014General Electric (GE) BuyStifel, Nicolaus & Co., Inc.
23.06.2014General Electric (GE) kaufenIndependent Research GmbH
19.12.2013General Electric (GE) kaufenIndependent Research GmbH
17.12.2014General Electric (GE) OutperformRBC Capital Markets
25.11.2014General Electric (GE) OutperformRBC Capital Markets
17.09.2014General Electric (GE) BuyStifel, Nicolaus & Co., Inc.
23.06.2014General Electric (GE) kaufenIndependent Research GmbH
19.12.2013General Electric (GE) kaufenIndependent Research GmbH
22.07.2013General Electric (GE) haltenBernstein
21.03.2013General Electric (GE) haltenMorgan Stanley
29.01.2013General Electric (GE) haltenHamburger Sparkasse AG (Haspa)
18.12.2012General Electric (GE) haltenIndependent Research GmbH
24.10.2012General Electric (GE) haltenHamburger Sparkasse AG (Haspa)
04.12.2009General Electric reduzierenIndependent Research GmbH
19.10.2009General Electric reduzierenIndependent Research GmbH
20.07.2009General Electric reduzierenIndependent Research GmbH
20.04.2009General Electric reduzierenIndependent Research GmbH
26.01.2009General Electric reduzierenIndependent Research GmbH
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für General Electric (GE) Co. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen
Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"

mehr General Electric (GE) Co. Analysen
Für den Live-Chat können Sie sich mit Ihrem finanzen.net-, Facebook- oder Twitter Account anmelden. Um immer die neusten Beiträge zu sehen, stellen Sie bitte "Neuesten" ein.

Anzeige

Heute im Fokus

DAX geht schwächer ins Wochenende -- MorphoSys-Aktie und Roche-Aktie fallen kräftig -- US-Börsen in der Gewinnzone -- GfK-Konsumklima auf höchstem Stand seit acht Jahren

BayernLB verklagt Ecclestone. Euro gibt leicht nach. Studio Babelsberg erwartet für 2014 Millionenverlust. Sartorius verkauft Sparte. Ölpreise deutlich gestiegen. Verdi ruft an vier Amazon-Standorten zu Streiks bis Heiligabend auf. Allianz stimmt Vergleich nach Amoklauf von Winnenden zu. Facebook will mehr über Datenschutz informieren.
Diese Aktien sind auf den Kauflisten der Experten

Welche Unternehmen sind am attraktivsten für Informatiker?

Diese Flughäfen werden hoch frequentiert

Die 5 beliebtesten Top-Rankings

So viel erhalten die Deutschen

Aktien-Profiteure der Cannabis-Legalisierung in den USA

Mit welchen Techniken sparen Weltkonzerne Steuern?

Welche sind die reichsten Amerikaner unter 40 Jahren?

Wenn Zukunft Gegenwart wird

mehr Top Rankings

Umfrage

Bundeskanzlerin Angela Merkel will sich mit Haut und Haar für das Freihandelsabkommen mit den USA stark machen. Was halten Sie von TTIP?